Mirogabalin for central neuropathic pain after spinal cord injury: a randomized, double-blind, placebo-controlled, phase 3 study in Asia

T Ushida, Y Katayama, Y Hiasa, M Nishihara, F Tajima… - Neurology, 2023 - AAN Enterprises
randomization and the first administration of the study drug, … 12-week randomized study of
patients with SCI reported … The change in SF-MPQ VAS score at week 14 in our study was −…

A 6-week, phase IIb, randomized, double-blind, placebo-controlled trial of Anyu Peibo capsules for the treatment of major depressive disorder in adults

S He, Y Yu, J Huang, J Yin, Y Niu, Y Lu… - Therapeutic …, 2023 - journals.sagepub.com
patients do not respond to conventional antidepressant … The change in the MADRS total
score from baseline to week 6 … Furthermore, this study is the first to report on the efficacy …

Vortioxetine in major depressive disorder: from mechanisms of action to clinical studies. An updated review

J De Diego-Adeliño, JM Crespo, F Mora… - Expert opinion on …, 2022 - Taylor & Francis
… the 21 newest antidepressants for the acute treatment of MDD, … Undoubtedly, larger
double-blind randomized CT are … -up) open-label randomized study comparing the effectiveness …

… Double-Blind Study Comparing Fib-19-01, A Phytotherapy Treatment, To A Dietary Supplement And To Conventional Care In Patients Suffering From Fibromyalgia.

M Barmaki, C Maindet-Dominici… - … Therapies in Health …, 2019 - search.ebscohost.com
… Isabelle Russ, MD, is Pôle de prise en charge de la douleur, … ) and a high frequency of
antidepressant and anticonvulsant … AND randomized trials” only 10 randomized clinical trials

[HTML][HTML] … 5, 10, and 20 mg significantly reduces the risk of relapse compared with placebo in patients with remitted major depressive disorder: The RESET study

ME Thase, PL Jacobsen, E Hanson, R Xu… - Journal of Affective …, 2022 - Elsevier
… After successful acute treatment with antidepressantstudy comparing maintenance of dosing
versus switching to … and the first participant entered the randomized double-blind period on …

Efficacy and safety of celecoxib for treatment of mild to moderate postpartum depression: A randomized, double-blind, placebo-controlled trial

S Esalatmanesh, L Kashani, M Khooshideh… - Archives of Gynecology …, 2024 - Springer
… , this study was the first double-blind clinical trial to evaluate … in patients with MDD who
were treated with antidepressant … -6 concentration and depression severity and change in the …

[HTML][HTML] Effectiveness of vortioxetine in patients with major depressive disorder and early-stage dementia: The MEMORY study

MC Christensen, SN Schmidt, I Grande - Journal of Affective Disorders, 2023 - Elsevier
randomized, double-blind, placebo-controlled trials found little or no effect of antidepressants
(… This is comparable to the change seen in the overall study population, demonstrating that …

… in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

MD Ferrari, HC Diener, X Ning, M Galic, JM Cohen… - The Lancet, 2019 - thelancet.com
… In fact, most trials of conventional migraine preventive … after the first dose of study drug and
the change from baseline in … Anticonvulsants, β blockers, and tricyclic antidepressants were …

[HTML][HTML] Trial of SAGE-217 in patients with major depressive disorder

H Gunduz-Bruce, C Silber, I Kaul… - … England Journal of …, 2019 - Mass Medical Soc
… The primary end point was the change from baseline to day 15 in the … of depression with
antidepressants. Placebo-controlled … of a randomized, double-blind, placebo-controlled trial of …

Curcumin as add-on to antipsychotic treatment in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study

C Miodownik, V Lerner, N Kudkaeva… - Clinical …, 2019 - journals.lww.com
… -on agent in patients with major depression. Curcumin-treated … to the tricyclic antidepressant
imipramine. Curcumin not only … In another parallel group randomized trial, 15 patients with …